Krystal Biotech (KRYS) Cash & Equivalents (2016 - 2026)
Krystal Biotech (KRYS) posted Cash & Equivalents of $427.74 million for Q2 2026, up 20.9% from $353.83 million a year earlier but down 14.7% from the prior quarter.
Powered by 
Analysis
Krystal Biotech (KRYS) Cash & Equivalents (2016 - 2026) Analysis & Trends
At the end of FY2025, Krystal Biotech's Cash & Equivalents came in at $496.3 million, up 43.9% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of 13.1% (FY2020 to FY2025).
- In prior years, Krystal Biotech's Cash & Equivalents was $344.87 million in FY2024 (-3.8%), $358.33 million in FY2023 (+121.3%), $161.9 million in FY2022 (-52.6%) and $341.25 million in FY2021 (+27.2%).
- Quarterly Cash & Equivalents has run from a low of $140.75 million in Q1 2023 to a high of $501.31 million in Q1 2026 over five years.
- On a year-over-year basis, Cash & Equivalents has increased in each of the last five quarters, with growth averaging 14.6% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q1 2024, with growth of 155.1%; the weakest was Q4 2022, with a decline of 52.6%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $501.31 million (Q1 2026), $496.3 million (Q4 2025) and $392.6 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Krystal Biotech | 9.54 Bn | 6.31 Bn | 112.79 Mn | 427.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 427.74 Mn |
| Mar 31, 2026 | 501.31 Mn |
| Dec 31, 2025 | 496.30 Mn |
| Sep 30, 2025 | 392.60 Mn |
| Jun 30, 2025 | 353.83 Mn |
| Mar 31, 2025 | 308.77 Mn |
| Dec 31, 2024 | 344.87 Mn |
| Sep 30, 2024 | 373.97 Mn |
| Jun 30, 2024 | 345.79 Mn |
| Mar 31, 2024 | 359.01 Mn |
| Dec 31, 2023 | 358.33 Mn |
| Sep 30, 2023 | 373.24 Mn |
| Jun 30, 2023 | 275.88 Mn |
| Mar 31, 2023 | 140.75 Mn |
| Dec 31, 2022 | 161.90 Mn |
| Sep 30, 2022 | 186.41 Mn |
| Jun 30, 2022 | 218.72 Mn |
| Mar 31, 2022 | 269.30 Mn |
| Dec 31, 2021 | 341.25 Mn |
| Sep 30, 2021 | 286.61 Mn |
API Access
Krystal Biotech Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=KRYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "KRYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=KRYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();